ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-1K9619
Home | Market Reports | Science| Biological Sciences
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Insights and Forecast to 2028
BUY CHAPTERS

Global Calcitonin Gene Related Peptide Type 1 Receptor Market Research Report 2025

Code: QYRE-Auto-1K9619
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck& Co. Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc
Merck& Co. Inc

Calcitonin Gene Related Peptide Type 1 Receptor Market

The global market for Calcitonin Gene Related Peptide Type 1 Receptor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Calcitonin Gene Related Peptide Type 1 Receptor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Calcitonin Gene Related Peptide Type 1 Receptor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor include Allergan Plc, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Eli Lilly and Company, Fortress Biotech Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Vertex Pharmaceuticals Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Calcitonin Gene Related Peptide Type 1 Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcitonin Gene Related Peptide Type 1 Receptor.
The Calcitonin Gene Related Peptide Type 1 Receptor market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Calcitonin Gene Related Peptide Type 1 Receptor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcitonin Gene Related Peptide Type 1 Receptor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Calcitonin Gene Related Peptide Type 1 Receptor Market Report

Report Metric Details
Report Name Calcitonin Gene Related Peptide Type 1 Receptor Market
Segment by Type
  • AFAP-3
  • AGN-241689
  • CGRP
  • Erenumab
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan Plc, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Eli Lilly and Company, Fortress Biotech Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Vertex Pharmaceuticals Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Calcitonin Gene Related Peptide Type 1 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Calcitonin Gene Related Peptide Type 1 Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Calcitonin Gene Related Peptide Type 1 Receptor Market report?

Ans: The main players in the Calcitonin Gene Related Peptide Type 1 Receptor Market are Allergan Plc, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Eli Lilly and Company, Fortress Biotech Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Vertex Pharmaceuticals Inc

What are the Application segmentation covered in the Calcitonin Gene Related Peptide Type 1 Receptor Market report?

Ans: The Applications covered in the Calcitonin Gene Related Peptide Type 1 Receptor Market report are Cardiovascular, Metabolic Disorders, Dental Pain, Others

What are the Type segmentation covered in the Calcitonin Gene Related Peptide Type 1 Receptor Market report?

Ans: The Types covered in the Calcitonin Gene Related Peptide Type 1 Receptor Market report are AFAP-3, AGN-241689, CGRP, Erenumab, Others

Recommended Reports

Peptide Drug Markets

Gene Therapy Products

Receptor & Diagnostics

1 Calcitonin Gene Related Peptide Type 1 Receptor Market Overview
1.1 Product Definition
1.2 Calcitonin Gene Related Peptide Type 1 Receptor by Type
1.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Value Comparison by Type (2024 VS 2031)
1.2.2 AFAP-3
1.2.3 AGN-241689
1.2.4 CGRP
1.2.5 Erenumab
1.2.6 Others
1.3 Calcitonin Gene Related Peptide Type 1 Receptor by Application
1.3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Value by Application (2024 VS 2031)
1.3.2 Cardiovascular
1.3.3 Metabolic Disorders
1.3.4 Dental Pain
1.3.5 Others
1.4 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Estimates and Forecasts
1.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue 2020-2031
1.4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales 2020-2031
1.4.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Calcitonin Gene Related Peptide Type 1 Receptor Market Competition by Manufacturers
2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Manufacturers (2020-2025)
2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Calcitonin Gene Related Peptide Type 1 Receptor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, Product Type & Application
2.7 Global Key Manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, Date of Enter into This Industry
2.8 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Competitive Situation and Trends
2.8.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Calcitonin Gene Related Peptide Type 1 Receptor Players Market Share by Revenue
2.8.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Scenario by Region
3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region: 2020-2031
3.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region: 2020-2025
3.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region: 2026-2031
3.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region: 2020-2031
3.3.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region: 2020-2025
3.3.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region: 2026-2031
3.4 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Country
3.4.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2031)
3.4.3 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Country
3.5.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2031)
3.5.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Region
3.6.1 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2020-2031)
3.6.3 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Country
3.7.1 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2031)
3.7.3 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Country
3.8.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2031)
3.8.3 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2020-2031)
4.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2020-2025)
4.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2026-2031)
4.1.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2020-2031)
4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2020-2031)
4.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2020-2025)
4.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2026-2031)
4.2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Type (2020-2031)
4.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Type (2020-2031)
5 Segment by Application
5.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2020-2031)
5.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2020-2025)
5.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2026-2031)
5.1.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2020-2031)
5.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2020-2031)
5.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2020-2025)
5.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2026-2031)
5.2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application (2020-2031)
5.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan Plc
6.1.1 Allergan Plc Company Information
6.1.2 Allergan Plc Description and Business Overview
6.1.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.1.5 Allergan Plc Recent Developments/Updates
6.2 Amgen Inc
6.2.1 Amgen Inc Company Information
6.2.2 Amgen Inc Description and Business Overview
6.2.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.2.5 Amgen Inc Recent Developments/Updates
6.3 Biohaven Pharmaceutical Holding Company Ltd
6.3.1 Biohaven Pharmaceutical Holding Company Ltd Company Information
6.3.2 Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
6.3.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.3.5 Biohaven Pharmaceutical Holding Company Ltd Recent Developments/Updates
6.4 Eli Lilly and Company
6.4.1 Eli Lilly and Company Company Information
6.4.2 Eli Lilly and Company Description and Business Overview
6.4.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.4.5 Eli Lilly and Company Recent Developments/Updates
6.5 Fortress Biotech Inc
6.5.1 Fortress Biotech Inc Company Information
6.5.2 Fortress Biotech Inc Description and Business Overview
6.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.5.5 Fortress Biotech Inc Recent Developments/Updates
6.6 Merck & Co Inc
6.6.1 Merck & Co Inc Company Information
6.6.2 Merck & Co Inc Description and Business Overview
6.6.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.6.5 Merck & Co Inc Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd
6.7.1 Teva Pharmaceutical Industries Ltd Company Information
6.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.7.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.8 Vertex Pharmaceuticals Inc
6.8.1 Vertex Pharmaceuticals Inc Company Information
6.8.2 Vertex Pharmaceuticals Inc Description and Business Overview
6.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product Portfolio
6.8.5 Vertex Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calcitonin Gene Related Peptide Type 1 Receptor Industry Chain Analysis
7.2 Calcitonin Gene Related Peptide Type 1 Receptor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calcitonin Gene Related Peptide Type 1 Receptor Production Mode & Process Analysis
7.4 Calcitonin Gene Related Peptide Type 1 Receptor Sales and Marketing
7.4.1 Calcitonin Gene Related Peptide Type 1 Receptor Sales Channels
7.4.2 Calcitonin Gene Related Peptide Type 1 Receptor Distributors
7.5 Calcitonin Gene Related Peptide Type 1 Receptor Customer Analysis
8 Calcitonin Gene Related Peptide Type 1 Receptor Market Dynamics
8.1 Calcitonin Gene Related Peptide Type 1 Receptor Industry Trends
8.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Drivers
8.3 Calcitonin Gene Related Peptide Type 1 Receptor Market Challenges
8.4 Calcitonin Gene Related Peptide Type 1 Receptor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Allergan plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck& Co. Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc
Merck& Co. Inc
List of Tables
 Table 1. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Calcitonin Gene Related Peptide Type 1 Receptor Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Calcitonin Gene Related Peptide Type 1 Receptor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, Product Type & Application
 Table 12. Global Key Manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Calcitonin Gene Related Peptide Type 1 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcitonin Gene Related Peptide Type 1 Receptor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2020-2025)
 Table 19. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2026-2031)
 Table 21. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2020-2025)
 Table 23. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2026-2031)
 Table 25. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2020-2025)
 Table 53. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2026-2031)
 Table 54. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Type (2020-2025)
 Table 57. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Type (2026-2031)
 Table 58. Global Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2020-2025)
 Table 63. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2026-2031)
 Table 64. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application (2020-2025)
 Table 67. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application (2026-2031)
 Table 68. Global Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Application (2026-2031)
 Table 70. Allergan Plc Company Information
 Table 71. Allergan Plc Description and Business Overview
 Table 72. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 74. Allergan Plc Recent Developments/Updates
 Table 75. Amgen Inc Company Information
 Table 76. Amgen Inc Description and Business Overview
 Table 77. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 79. Amgen Inc Recent Developments/Updates
 Table 80. Biohaven Pharmaceutical Holding Company Ltd Company Information
 Table 81. Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
 Table 82. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 84. Biohaven Pharmaceutical Holding Company Ltd Recent Developments/Updates
 Table 85. Eli Lilly and Company Company Information
 Table 86. Eli Lilly and Company Description and Business Overview
 Table 87. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 89. Eli Lilly and Company Recent Developments/Updates
 Table 90. Fortress Biotech Inc Company Information
 Table 91. Fortress Biotech Inc Description and Business Overview
 Table 92. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 94. Fortress Biotech Inc Recent Developments/Updates
 Table 95. Merck & Co Inc Company Information
 Table 96. Merck & Co Inc Description and Business Overview
 Table 97. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 99. Merck & Co Inc Recent Developments/Updates
 Table 100. Teva Pharmaceutical Industries Ltd Company Information
 Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 102. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 105. Vertex Pharmaceuticals Inc Company Information
 Table 106. Vertex Pharmaceuticals Inc Description and Business Overview
 Table 107. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product
 Table 109. Vertex Pharmaceuticals Inc Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Calcitonin Gene Related Peptide Type 1 Receptor Distributors List
 Table 113. Calcitonin Gene Related Peptide Type 1 Receptor Customers List
 Table 114. Calcitonin Gene Related Peptide Type 1 Receptor Market Trends
 Table 115. Calcitonin Gene Related Peptide Type 1 Receptor Market Drivers
 Table 116. Calcitonin Gene Related Peptide Type 1 Receptor Market Challenges
 Table 117. Calcitonin Gene Related Peptide Type 1 Receptor Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Calcitonin Gene Related Peptide Type 1 Receptor
 Figure 2. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Type: 2024 & 2031
 Figure 4. AFAP-3 Product Picture
 Figure 5. AGN-241689 Product Picture
 Figure 6. CGRP Product Picture
 Figure 7. Erenumab Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Application: 2024 & 2031
 Figure 11. Cardiovascular
 Figure 12. Metabolic Disorders
 Figure 13. Dental Pain
 Figure 14. Others
 Figure 15. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales (2020-2031) & (K Pcs)
 Figure 18. Global Calcitonin Gene Related Peptide Type 1 Receptor Average Price (USD/Pcs) & (2020-2031)
 Figure 19. Calcitonin Gene Related Peptide Type 1 Receptor Report Years Considered
 Figure 20. Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Manufacturers in 2024
 Figure 21. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Calcitonin Gene Related Peptide Type 1 Receptor Players: Market Share by Revenue in Calcitonin Gene Related Peptide Type 1 Receptor in 2024
 Figure 23. Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 26. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 30. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2020-2031)
 Figure 38. China Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Type (2020-2031)
 Figure 60. Global Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Calcitonin Gene Related Peptide Type 1 Receptor by Application (2020-2031)
 Figure 63. Global Calcitonin Gene Related Peptide Type 1 Receptor Price (USD/Pcs) by Application (2020-2031)
 Figure 64. Calcitonin Gene Related Peptide Type 1 Receptor Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Calcitonin Antibody Market Research Report 2024
Global CGRP Receptor Antagonists Market Research Report 2024
Global Salmon Calcitonin Market Insights Forecast to 2030
Global Growth Hormone Secretagogue Receptor Type 1 Market Research Report 2024
Pharmaceutical Grade Salmon Calcitonin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CGRP Monoclonal Antibodies Market Research Report 2024
Global Activin Receptor Type 1 Market Research Report 2024
Global Calcitonin Salmon API Market Research Report 2025
Global Tachykinin Receptor 1 Antibody Market Research Report 2024
Global Nociceptin Receptor Market Research Report 2024
Global Salmon Calcitonin Acetate Market Research Report 2025
Global Metabotropic Glutamate Receptor 1 Market Research Report 2025
G protein Coupled Receptor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Like Growth Factor 1 Receptor Market Research Report 2024
Global Somatostatin Receptor Type 4 Market Research Report 2024
Global Neuropeptide Y Receptor Type 2 Market Research Report 2024
Global Glucagon Like Peptide 2 Receptor Market Research Report 2024
Recombinant Human Procalcitonin Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclic Peptide Compounds Market Research Report 2024
Global Toll Like Receptor 4 Market Research Report 2025

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions